Safety of tenecteplase vs. alteplase in telestroke: a large multistate experience (STAT)
IntroductionPrompt treatment with IV thrombolytics (IVT) in acute ischemic stroke (AIS) patients is critical for improved recovery and survival. Recently, hospital systems have switched to the IVT tenecteplase (TNK) instead of the FDA-approved alteplase (tPA) for treatment. Multiple studies and meta...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1514915/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841555669276164096 |
|---|---|
| author | Morgan Figurelle Sandro Corti Oleg Collins Lan Gao Amanda Avila Kristie Delfino Laurie Mayer Theresa Sevilis |
| author_facet | Morgan Figurelle Sandro Corti Oleg Collins Lan Gao Amanda Avila Kristie Delfino Laurie Mayer Theresa Sevilis |
| author_sort | Morgan Figurelle |
| collection | DOAJ |
| description | IntroductionPrompt treatment with IV thrombolytics (IVT) in acute ischemic stroke (AIS) patients is critical for improved recovery and survival. Recently, hospital systems have switched to the IVT tenecteplase (TNK) instead of the FDA-approved alteplase (tPA) for treatment. Multiple studies and meta-analyses evaluating the efficacy and safety of TNK demonstrate similar or superior outcomes when compared to tPA. TNK is not FDA-approved for treatment, which has led to hesitation in its use and increased attention on its complication profile, including the risk of intracranial hemorrhage (ICH).MethodsData from AIS consults conducted in the emergency departments of 220 facilities across 26 states, between 1 January 2022 and 31 May 2023, were extracted from the TeleCare by TeleSpecialists™ database. The encounters were reviewed for IVT candidates, door-to-needle (DTN) time, type of IVT administered, use of advanced imaging, presence of LVO, occurrence and type of complications, complication type, symptomatic ICH, and the ECASS II ICH score.ResultsA total of 2,305 TNK patients and 3,337 tPA patients were extracted. DTN times were faster (37 min vs. 42 min, p < 0.0001), and more total complications were observed in the TNK group (87 vs. 80, p = 0.0035). In non-LVO IVT patients, the TNK group had more complications (57 vs. 47, p = 0.0078), specifically ICH (48 vs. 35, p = 0.0036). No statistically significant difference in the incidence of ICH was observed between the TNK group and the tPA group (21 vs. 18, p = 0.07). In IVT patients not accepted for NIR, the TNK group had more complications (77 vs. 69, p = 0.005), specifically ICH (63 vs. 51, p = 0.0026). In IVT patients accepted for NIR, no significant differences were observed. There were no statistically significant differences in symptomatic ICH between the groups.ConclusionThe TNK group was found to have significantly more complications, including ICH, than the tPA group driven by non-LVO patients. A closer analysis of the potential for increased risk to non-LVO patients is warranted based on this large, multistate, and multi-hospital system study. |
| format | Article |
| id | doaj-art-47c8e7c15a49475d98cabbf73891f8a3 |
| institution | Kabale University |
| issn | 1664-2295 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Neurology |
| spelling | doaj-art-47c8e7c15a49475d98cabbf73891f8a32025-01-08T05:10:25ZengFrontiers Media S.A.Frontiers in Neurology1664-22952025-01-011510.3389/fneur.2024.15149151514915Safety of tenecteplase vs. alteplase in telestroke: a large multistate experience (STAT)Morgan Figurelle0Sandro Corti1Oleg Collins2Lan Gao3Amanda Avila4Kristie Delfino5Laurie Mayer6Theresa Sevilis7TeleSpecialists, LLC, Fort Myers, FL, United StatesTeleSpecialists, LLC, Fort Myers, FL, United StatesDepartment of Mathematics, University of Tennessee at Chattanooga, Chattanooga, TN, United StatesDepartment of Mathematics, University of Tennessee at Chattanooga, Chattanooga, TN, United StatesTeleSpecialists, LLC, Fort Myers, FL, United StatesTeleSpecialists, LLC, Fort Myers, FL, United StatesTeleSpecialists, LLC, Fort Myers, FL, United StatesTeleSpecialists, LLC, Fort Myers, FL, United StatesIntroductionPrompt treatment with IV thrombolytics (IVT) in acute ischemic stroke (AIS) patients is critical for improved recovery and survival. Recently, hospital systems have switched to the IVT tenecteplase (TNK) instead of the FDA-approved alteplase (tPA) for treatment. Multiple studies and meta-analyses evaluating the efficacy and safety of TNK demonstrate similar or superior outcomes when compared to tPA. TNK is not FDA-approved for treatment, which has led to hesitation in its use and increased attention on its complication profile, including the risk of intracranial hemorrhage (ICH).MethodsData from AIS consults conducted in the emergency departments of 220 facilities across 26 states, between 1 January 2022 and 31 May 2023, were extracted from the TeleCare by TeleSpecialists™ database. The encounters were reviewed for IVT candidates, door-to-needle (DTN) time, type of IVT administered, use of advanced imaging, presence of LVO, occurrence and type of complications, complication type, symptomatic ICH, and the ECASS II ICH score.ResultsA total of 2,305 TNK patients and 3,337 tPA patients were extracted. DTN times were faster (37 min vs. 42 min, p < 0.0001), and more total complications were observed in the TNK group (87 vs. 80, p = 0.0035). In non-LVO IVT patients, the TNK group had more complications (57 vs. 47, p = 0.0078), specifically ICH (48 vs. 35, p = 0.0036). No statistically significant difference in the incidence of ICH was observed between the TNK group and the tPA group (21 vs. 18, p = 0.07). In IVT patients not accepted for NIR, the TNK group had more complications (77 vs. 69, p = 0.005), specifically ICH (63 vs. 51, p = 0.0026). In IVT patients accepted for NIR, no significant differences were observed. There were no statistically significant differences in symptomatic ICH between the groups.ConclusionThe TNK group was found to have significantly more complications, including ICH, than the tPA group driven by non-LVO patients. A closer analysis of the potential for increased risk to non-LVO patients is warranted based on this large, multistate, and multi-hospital system study.https://www.frontiersin.org/articles/10.3389/fneur.2024.1514915/fulltenecteplasealteplasetelestrokeacute stroke carethrombolytics |
| spellingShingle | Morgan Figurelle Sandro Corti Oleg Collins Lan Gao Amanda Avila Kristie Delfino Laurie Mayer Theresa Sevilis Safety of tenecteplase vs. alteplase in telestroke: a large multistate experience (STAT) Frontiers in Neurology tenecteplase alteplase telestroke acute stroke care thrombolytics |
| title | Safety of tenecteplase vs. alteplase in telestroke: a large multistate experience (STAT) |
| title_full | Safety of tenecteplase vs. alteplase in telestroke: a large multistate experience (STAT) |
| title_fullStr | Safety of tenecteplase vs. alteplase in telestroke: a large multistate experience (STAT) |
| title_full_unstemmed | Safety of tenecteplase vs. alteplase in telestroke: a large multistate experience (STAT) |
| title_short | Safety of tenecteplase vs. alteplase in telestroke: a large multistate experience (STAT) |
| title_sort | safety of tenecteplase vs alteplase in telestroke a large multistate experience stat |
| topic | tenecteplase alteplase telestroke acute stroke care thrombolytics |
| url | https://www.frontiersin.org/articles/10.3389/fneur.2024.1514915/full |
| work_keys_str_mv | AT morganfigurelle safetyoftenecteplasevsalteplaseintelestrokealargemultistateexperiencestat AT sandrocorti safetyoftenecteplasevsalteplaseintelestrokealargemultistateexperiencestat AT olegcollins safetyoftenecteplasevsalteplaseintelestrokealargemultistateexperiencestat AT langao safetyoftenecteplasevsalteplaseintelestrokealargemultistateexperiencestat AT amandaavila safetyoftenecteplasevsalteplaseintelestrokealargemultistateexperiencestat AT kristiedelfino safetyoftenecteplasevsalteplaseintelestrokealargemultistateexperiencestat AT lauriemayer safetyoftenecteplasevsalteplaseintelestrokealargemultistateexperiencestat AT theresasevilis safetyoftenecteplasevsalteplaseintelestrokealargemultistateexperiencestat |